IL6 and myelodysplastic syndrome: Increased levels of CXCL10, IL-6, and IL-7 are associated with shorter MDS survival compared to patients with normal levels of these cytokines irrespective of age, transfusion burden, degree of cytopenias, and IPSS score [25].